Tuberculosis is a devastating disease caused by Mycobacterium tuberculosis. If left untreated or not properly treated, it could lead to progressive tissue damage and even death. Short-term chemotherapy containing isoniazid, rifampicin. and pyrazinamide were proven to be very effective in the treatment of TB. However, the concern regarding its potential hepatotoxicity might hinder the completion of treatment. Information regarding risk factor of hepatotoxicity among Indonesian tuberculosis patients were limited. This study aimed to investigate risk factors of hepatotoxicity among Indonesian tuberculosis patients. This was a case-control study with retrospective approach conducted at one of the public hospital in Lampung, Indonesia. We included 320 tuberculosis patients who were classified as case (64 patients who were diagnosed with hepatotoxicity during hospitalization) and control (256 patients). Results of multivariate logistic regression analysis showed that age was significant risk factor of hepatotoxicity (adjusted odds ratio (OR) 1.056, 95% CI 1.0121, 1.091), while longer duration of hospitalization had a 1.4 lower odds of hepatotoxicity compared to control (adjusted OR 0.757, 95% CI 0.682, 0.839) (p<0.005). The results indicated that older patients were more likely to have hepatotoxicity, while patients with shorter duration of hospitalization tend to have higher risk of hepatotoxicity. In conclusion, age was the risk factor associated with hepatotoxicity among tuberculosis patients.
Introduction
Tuberculosis remains a major global public health problem, causing approximately 10 million deaths annually. It is caused by Mycobacterium tuberculosis. If left untreated or not properly treated, it could lead to progressive tissue damage and even death.
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Short-term chemotherapy containing isoniazid (INH), rifampicin (RMP) and pyrazinamid (PZA) were shown to be very effective in the treatment of TB. However, previous study showed that about 15% of the patients could not complete the treatment doi: 10.15416/pcpr.2018.1.1. 10 Corresponding author: Muhammad F. Wardhana. Dr. H. Abdul Moeloek General Hospital, Bandar Lampung, Lampung, Indonesia. Email: fitrawardhana23@gmail.com due to adverse effect associated with tuberculosis drugs. Hepatotoxicity is one of the most common adverse effect causing discontinuation of treatment with INH, RMP, and PZA. 3 The time interval between initial antituberculosis treatment and the onset of symptoms of hepatotoxicity varies between 3-135 days. In most cases, hepatitis occurs within three months from the beginning of anti-tuberculosis treatment. 4 The pathogenesis of drug-induced hepatotoxicity is still not completely clear. Hypersensitivity is a possible cause of RMP inducing hepatitis, occurring as part of systemic allergic reaction due to unconjugated hyperbilirubinemia which is the result of competition with bilirubin for absorption in plasma hepatocyte membranes. RMP induced hepatotoxicity is more prevalent than that of INH. 5, 6 Indonesia is one of the country with highest tuberculosis burden, worldwide. Information regarding risk factor of hepatotoxicity among Indonesian tuberculosis patients were limited. This study aimed to investigate risk factors of hepatotoxicity among Indonesian tuberculosis patients.
Methods

Research subject and data retrieval
This was a case-control study with retrospective approach conducted at one of the public hospital in Lampung, Indonesia. This study was approved by Health Research Ethics Committee, Faculty of Medicine, Universitas Padjadjaran. This study extracted the data from patient medical records. In this study, the case was a group of tuberculosis patients who experienced hepatotoxicity during hospitalization. The controls were patients who did not experience hepatotoxicity. Criteria for the case were subjects who received first-line antituberculosis treatment for at least two months until the onset of symptoms of hepatotoxicity occurred.
Subjects were recruited by purposive sampling method, a non-probability sampling method based on the judgment of the clinical investigators. The inclusion criteria in this study were tuberculosis patients admitted to one public hospital in Lampung, Indonesia during January 2014 to December 2015, aged 18-60 years, had complete medical data, and had normal baseline liver function, i.e., aspartate aminotransferase (AST) <48 u/l, alanine aminotransferase (ALT) <55 u/l, serum bilirubin <1.5 mg/dl.
The exclusion criteria in this study were tuberculosis patients who received other drugs known to be metabolized by the liver (by cytochrome P450 3A4 or P-glycoprotein), experienced multidrug resistant tuberculosis (MDR-TB), were diagnosed with hepatitis A, B, C or E or carrier for HBV & HCV, HIVpositive patients, had chronic liver disease, consumed another hepatotoxic drugs, such as methotrexate, phenytoin, and valproate, experienced malabsorption or drug abuse, were pregnant and lactating women, and had incomplete medical data.
Measurement of variables
The independent variables measured in this study were the clinical characteristics that were estimated to induce hepatotoxicity, i.e., age, sex, concurrent disease, alcohol consumption, duration of tuberculosis treatment, concomitant medication, and duration of hospitalization. The dependent 
Results and Discussion
We included 320 tuberculosis patients who were classified as case (64 patients diagnosed with hepatotoxicity during hospitalization) and control (256 patients). The subjects were in the either intensive or advanced tuberculosis treatment phase. About half (57.8%) of the subjects were male. The mean age of the subjects was 36.8 years. The mean duration of TB treatment was 3.21 months, while the mean of length of hospitalization was 9.8 days.
Bivariate analysis results can be found in Table 2 . Bivariate analysis showed that there was no association between the presence of comorbidities, the use of concomitant medications, and alcohol consumption on the risk of hepatotoxicity. Age and the length of hospitalization influenced the risk of hepatotoxicity.
The same findings were observed in multivariate logistic regression analysis showing that that age was significant risk factor of hepatotoxicity (adjusted odds ratio Hepatotoxicity may occur at appropriate doses at any time during treatment. It could In contrast with previous finding, 9 we observed that alcohol consumption was not significantly associated with druginduced hepatotoxicity. However, the OR was more than 1 (adjusted OR 1.353 95% CI 0.493-3.711), which indicate positive association between alcohol consumption and hepatotoxicity. Relatively limited sample size in this study might prevent the findings from being extrapolated, which could result in different final result with other studies.
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Conclusion
In conclusion, age was the risk factor associated with hepatotoxicity among tuberculosis patients.
